Virginia Fitzpatrick

Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B

Greg Brown, John J. Albers, Lloyd D. Fisher et al. · New England Journal of Medicine · 1990 · 2.2K citations · Full text

Medicine, Cardiology, Pharmacology +17

Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints

G. Russell Warnick, Robert H. Knopp, Virginia Fitzpatrick et al. · Clinical Chemistry · 1990 · 570 citations

Life Sciences, Nutritional Sciences, Clinical Epidemiology +15

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty

J. Kereiakes, Neal S. Kleiman, John A. Ambrose et al. · Journal of the American College of Cardiology · 1996 · 226 citations · Full text

Medicine, Cardiology, Pharmacology +17

Population pharmacokinetics of CCI-779: Correlations to safety and pharmacogenomic responses in patients with advanced renal cancer

Joseph Boni, Cathie Leister, Gregor Bender et al. · Clinical Pharmacology & Therapeutics · 2005 · 87 citations

Medicine, Pharmacokinetics, Pharmacology +15

Relationship of self-effecacy to cholesterol lowering and dietary change in hyperlipidemia

Barbara S. McCann, Deborah J. Brief, C. W. Turner et al. · Annals of Behavioral Medicine · 1995 · 41 citations

Public Health, Health Behavior, Nutritional Sciences +17